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Scrapie is a naturally occurring prion (PrP) disease
causing a fatal neurodegenerative disorder in sheep and
goats. Previous studies suggest that scrapie is transmitted naturally through exposure to the scrapie agent in
wasted placentas of infected ewes. This study determined the distribution and biochemical properties of
PrP cellular (PrP-C) and the distribution of PrP scrapie
(PrP-Sc) in reproductive, placental, and selected fetal
tissues and fetal fluids in sheep. Glycosylated, N-terminally truncated, proteinase K-sensitive PrP-C with apparent molecular masses of 23–37 kDa was present in
reproductive, placental, and fetal tissues and fetal fluids. PrP-C was low or undetectable in intercotyledonary
chorioallantois, amnion, urachus, amniotic fluid, and
fetal urine. In pregnant ewes, cotyledonary chorioallantois, allantoic fluid, and caruncular endometrium contained higher levels of PrP-C than did intercaruncular
endometrium, myometrium, oviduct, ovary, fetal bladder, or fetal kidney. Caruncular endometrial PrP-C was
up-regulated during pregnancy. Despite the wide distribution of PrP-C in reproductive, placental, and selected
fetal tissues and fetal fluid, PrP-Sc was detected only in
caruncular endometrium and cotyledonary chorioallantois of pregnant scrapie-infected ewes. The embryo/fetus
may not be exposed to scrapie in utero because it is
separated physically from PrP-positive allantois and
chorioallantois by PrP-negative amnion.

Scrapie in sheep and goats is a naturally occurring fatal
neurodegenerative disorder characterized by accumulation of
the abnormally folded, PK1-resistant prion protein (PrP-Sc) (1,
2). In contrast to the ubiquitous distribution of the cellular,
PK-sensitive prion protein (PrP-C) (3, 4), PrP-Sc accumulation
in sheep is limited to the central and peripheral nervous system (5, 6), the lymphoreticular system (6), and placenta (7–9).
PrP-C is synthesized primarily as a glycosylphosphatidylinositol-anchored glycoprotein found in the cell membrane of a variety of cell types (10). A secretory form of PrP-C lacking the
glycosylphosphatidylinositol anchor is present in cell-free
translation systems, cell cultures, human cerebrospinal fluid,
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EXPERIMENTAL PROCEDURES

Animals and Tissue Collection—Uninfected (n ⫽ 10) and scrapieinfected (n ⫽ 4) Suffolk sheep were used. All uninfected ewes and rams
were from flocks with no reported history of scrapie and negative for
PrP-Sc by live animal testing (immunohistochemistry of third eyelid
lymphoid tissue) prior to mating, and no PrP-Sc was detected in brain
or lymphoid tissues by immunohistochemistry and Western blotting
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and platelets (11–15). Previous studies demonstrated that
PrP-C is the substrate for conversion to PrP-Sc and is required
for scrapie infection (16 –19).
Scrapie can be transmitted experimentally through multiple
routes (20). However, natural scrapie transmission may be
associated primarily with exposure to the infectious agent in
the placenta. Pattison et al. (7, 8) reported that oral inoculation
with placental membranes derived from scrapie-infected ewes
caused scrapie in both sheep and goats. Race et al. (9) recently
showed that PrP-Sc was detected by Western blotting in the
placenta from scrapie-infected ewes and scrapie infectivity in
tissue homogenates of placental membranes. Under natural
conditions, fetal fluids and placental tissues are expelled during or shortly after parturition and contaminate the body surface of the dam and the area where lambing takes place. Lambs
may be exposed to scrapie by ingesting the transmissible agent
during contact with contaminated wool and mammary gland of
the dam. Adult sheep in the same flock may also be exposed
orally through contaminated feed sources.
In the present study, we investigated the distribution of
PrP-C and biochemical properties of PrP-C and distribution of
PrP-Sc in the ovine female reproductive, placental, and selected fetal tissues and fetal fluids of infected and uninfected
ewes. In contrast to the ubiquitous distribution of PrP-C in the
female reproductive tract and conceptuses, PrP-Sc was present
only in the uterine caruncular endometrium and placental
cotyledonary chorioallantois of pregnant infected ewes. Nterminally truncated, glycosylated, PK-sensitive PrP-C with
apparent molecular masses of 23–37 kDa was present in cotyledonary chorioallantois, allantoic fluid, fetal bladder, and fetal
kidney as well as endometrium, myometrium, oviduct, and
ovary of pregnant and nonpregnant uninfected ewes. PrP-C
levels were low or undetectable in intercotyledonary chorioallantois, amnion, urachus, amniotic fluid, and fetal urine.
In pregnant ewes, cotyledonary chorioallantois, allantoic fluid,
or caruncular endometrium contained higher (p ⬍ 0.05) levels
of PrP-C than did intercaruncular endometrium, myometrium,
oviduct, ovary, fetal bladder, or fetal kidney. PrP-C expression
in caruncular endometrium was up-regulated (p ⬍ 0.05) during
pregnancy when compared with caruncular endometrial PrP-C
of nonpregnant ewes. Pregnancy status had no effect on PrP-C
expression in the brain, myometrium, oviduct, and ovary.
PrP-C detected in uninfected ewes had a protein core of
⬃18 –22 kDa in tissues and ⬃16.5 kDa in allantoic fluid.
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following necropsy (21, 22). Scrapie-infected ewes were identified by
positive third eyelid testing, and scrapie was confirmed by immunohistochemistry and Western blotting of brain and lymphoid tissue following necropsy. All sheep were homozygous for glutamine at codon 171 of
the PrP gene (23). Pregnant scrapie-infected ewes (n ⫽ 4) were mated to
rams at the United States Department of Agriculture research support
facility in Pullman and estimated to be near term pregnancy at euthanasia. The fetuses of these infected ewes were also homozygous for
glutamine at codon 171 of the PrP gene. Uninfected ewes (n ⫽ 6) were
checked daily for estrus in the presence of vasectomized rams and the
first day of exhibiting estrous behavior is referred to as Day 0 of the
estrous cycle. All ewes were mated to intact rams two to three times at
12-h intervals starting on Day 0 of the second estrous cycle. All pregnant uninfected ewes used in this study were 135–140 days pregnant
(full term pregnancy for sheep is 144 –150 days) at euthanasia. Reproductive tissues from nonpregnant uninfected ewes (n ⫽ 4) were also
examined. Sheep were fed with hay and alfalfa and had free access to
water. All sheep were euthanized immediately prior to necropsy. Maternal tissues (brain, uterine caruncular endometrium, and intercaruncular endometrium, uterine myometrium, oviduct, and ovary), fetal
tissues (brain, kidney, and bladder), placenta and fetal membranes
(cotyledonary and intercotyledonary chorioallantois, amnion, and urachus), and fetal fluids (allantoic fluid, amniotic fluid, and fetal urine)
were collected, frozen, and stored at ⫺80 °C until use (Fig. 1). Animal
care, handling, and use in this study were approved by the Institutional
Animal Care and Use Committee of Washington State University.
Antibodies—mAb 97/99 (recognizing an epitope between amino acid
residues 217 and 231 near the C terminus of the ovine PrP) and mAb
8H4 (recognizing epitopes between residues 146 and 200) were used to
identify PrP in ovine reproductive, fetal, and placental tissues and fetal
fluids (22, 24, 25). mAbs 5B2 and 8B4 (recognizing epitopes located at
amino acid residues 34 –52 and 36 – 43) were used to identify the presence of the N terminus of PrP-C (24, 25).

RESULTS

PrP-C Is Detected in the Uterine Endometrium, Myometrium,
Oviduct, and Ovary of Pregnant and Nonpregnant Normal
Ewes and Cotyledonary Chorioallantois, Fetal Bladder, and
Allantoic Fluid of Pregnant Normal Ewes—Representative



FIG. 1. A schematic representation of the ovine pregnant
uterus with a fetus and associated membranes and the placentome. A, pregnant uterus with fetus and fetal-associated membranes;
B, an ovine placentome. Sheep and goats possess a synepitheliochorial
placenta that is formed by interdigitation of villi of the uterine caruncular endometrium and placental cotyledonary chorioallantois. The
intercotyledonary portion of chorioallantois forms only diffuse attachment with the apposing uterine intercaruncular endometrial
epithelium.

Tissue Homogenate Preparation—Tissue homogenates were prepared with (for PrP-Sc detection) or without (for PrP-C detection) the
use of 10% Sarkosyl and ultracentrifugation. Tissue homogenates obtained in the absence of Sarkosyl (direct tissue homogenates) were
prepared from either fresh or frozen tissues. Briefly, tissues (100 mg)
were minced with scissors in microcentrifuge tubes or homogenized
with disposable tissue grinders. Homogenates were incubated at room
temperature for 1 h in 900 l of lysis buffer containing 10 mM Tris (pH
7.5), 0.5% Nonidet P-40, and 0.5% sodium deoxycholate. Tissue homogenates or fetal fluids were digested with or without PK (Roche Diagnostic Inc., Indianapolis, IN) at 20 g/ml for 30 min at 37 °C. PK
digestion was stopped by the addition of a protease inhibitor, Pefabloc
(Roche Diagnostic Inc., Indianapolis, IN), to a final concentration of 4
mM, and the reaction mixtures were stored at ⫺20 °C until analyzed by
electrophoresis and Western blotting. Tissue homogenates without PK
digestion were prepared in the presence of protease inhibitor mixture
following the manufacturer’s instructions (cmplete, Roche Diagnostic
Inc., Indianapolis, IN).
Tissue homogenates enriched for PrP-Sc (PrP-Sc-enriched tissue homogenates) by differential solubilization and ultracentrifugation obtained in the presence of 10% Sarkosyl were prepared as described by
Race et al. (9) with minor modifications. Briefly, fresh or frozen tissue
(up to 1 g) was minced, homogenized, and incubated at room temperature for 1 h in 10 mM Tris-HCl buffer (pH 7.5) containing 5 mM MgCl2.
An equal volume of Sarkosyl solution (20% Sarkosyl in 10 mM Tris-HCl
buffer (pH 7.5)) was added to tissue homogenates, which were centrifuged at 6,000 ⫻ g for 10 min; the resultant supernatants were collected
and centrifuged at 348,000 ⫻ g for 50 min at room temperature. The
pellets were dissolved in 10 mM Tris-HCl (pH 7.5) and treated with or
without PK (Roche Diagnostics Inc., Indianapolis, IN) as described
above. The preparations were centrifuged at 279,000 ⫻ g for 30 min,
and the pellets were resuspended in 10 mM Tris-HCl (pH 7.5) and boiled
for 5 min in sample loading buffer prior to analysis by Western blotting.
Western Blot Analysis—Tissue homogenates and fetal fluids were
analyzed by 14% SDS-polyacrylamide gel electrophoresis minigels (Invitrogen) followed by transfer using a semidry transblotter to polyvinylidene difluoride membranes (Millipore) prior to detection by mAbs
97/99, 8H4, 8B4, or 5B2. The membranes were incubated with goat
anti-mouse IgG-horseradish peroxidase (Southern Biotechnology
Associates, Inc., Birmington, AL), developed with a chemiluminescence
substrate (Amersham Pharmacia Biotech), and exposed to x-ray film
(Eastman Kodak Co.) for 1–10 min.
The relative levels of PrP-C in tissue homogenates and fetal fluids
were determined by densitometric analysis of films of Western blotting
using mAb 99/97. Briefly, fixed amounts of tissue homogenates (1.5
mg/lane of wet tissue equivalent) and fetal fluids (7.5 l/lane of allantoic, amniotic, or fetal urine) were analyzed by Western blotting as
described above. Brain tissue homogenate was analyzed at 0.15 mg/
lane, due to high levels of PrP-C present in the brain. All films were
exposed to Western blots for 1 min, and densitometry was performed
using a digital imaging system (ChemiImager 4000, Alpha Innotech
Corp., San Leandro, CA). The sensitivity of the assay was determined
by detecting serial dilutions of roPrP (21) (ranging from 1 to 600
ng/lane) suspended in tissue homogenates. Twenty-five nanograms of
roPrP were loaded on one lane of each gel to normalize the relative
levels of PrP-C in tissues and fluids. Results are expressed as relative
units, representing the ratio between densitometric values of sample
PrP-C and roPrP (25 ng).
Deglycosylation—Deglycosylation was conducted using a commercial
kit following the manufacturer’s instructions (Prozyme, Inc., San Leandro, CA). Briefly, 2 l of 5⫻ PNGase F buffer and 2 l of denaturation
solution were added to 1 l of brain homogenate plus 5 l of water or 6
l of extraneural tissue homogenate as prepared above (200 mg wet
tissue in 1 ml of lysis buffer), followed by incubation at 100 °C for 5 min.
After the reaction was cooled to room temperature, 1 l of Triton X-100
and 1 l of PNGase F were added and incubated at 37 °C overnight. The
reaction mixture was boiled for 5 min in sample loading buffer prior to
analyses by electrophoresis and Western blotting.
Statistics—Data were analyzed by one-way analysis of variance with
Student-Newman-Keuls multiple comparisons test. Probability values
less than 0.05 were considered statistical significant.

PrP-C and PrP-Sc at the Fetal-Maternal Interface

Western blot results of PrP-C in brain, reproductive, placental,
and selected fetal tissues and fetal fluids of six pregnant uninfected and four nonpregnant uninfected ewes are shown in Fig.
2, A–C. PrP-C was not detectable when the primary mAbs were
replaced by isotype control mAbs, nor when mAb 99/97 was
preabsorbed with the immunogen peptide to which mAb 99/97
was generated (data not shown).
Fetal brain (Fig. 2, A and B, lane f-bra) contained PrP-C at
an apparent molecular mass of ⬃25–38 kDa, similar to that in
maternal brain (Fig. 2, A—C, lane m-bra) when probed with
mAb 99/97 or 8H4. The molecular masses of these immunoreactive bands are consistent with the predicted molecular
masses of PrP-C in sheep (4).
PrP-C isoforms with apparent molecular masses of ⬃23–37
kDa were also detected by both mAbs 97/99 and 8H4 in tissue
homogenates of maternal reproductive tissues of both pregnant
and nonpregnant ewes (uterine intercaruncular and caruncular endometria, myometrium, oviduct, and ovary; Fig. 2, A—C,

lanes ica-end, ca-end, myo, ovi, and ova), fetal placenta (cotyledonary chorioallantois; Fig. 2, A and B, lane co-cho), fetal
fluid (allantoic fluid; Fig. 2, A and B, lane all-fl), and selected
fetal tissues (fetal bladder; Fig. 2, A and B, lane f-bla). These
PrP-C isoforms were either very low or undetectable in the
intercotyledonary chorioallantois, urachus, amnion, amniotic
fluid, fetal kidney, and fetal urine (Fig. 2, A and B, lanes
ico-cho, ura, amn, amn-fl, f-kid, and f-uri). One predominant
species of PrP-C was detected in cotyledonary chorioallantois
(⬃26 kDa), allantoic fluid (27 kDa), and fetal bladder (27 kDa)
(Fig. 2, A and B, lanes co-cho, all-fl, and f-bla).
Levels of PrP-C in Reproductive, Placental, and Fetal Tissues
and Fetal Fluids of Pregnant and Nonpregnant Uninfected
Ewes—Relative levels of PrP-C in fixed amounts of tissue
homogenates of maternal brain, caruncular endometrium, cotyledonary chorioallantois, intercotyledonary chorioallantois,
allantoic fluid, amniotic fluid, intercaruncular endometrium,
myometrium, oviduct, ovary, amnion, urachus, fetal urine, fetal bladder, fetal kidney, and fetal brain of pregnant ewes and
brain, caruncular endometrium, myometrium, oviduct, and
ovary of nonpregnant ewes were determined by Western blotting and densitometry (Fig. 3). The Western blot assay was
linear over a range of 3–200 ng of roPrP per lane in the
presence or absence of 10% tissue homogenates (data not
shown).
Levels of PrP-C in brains of pregnant, nonpregnant, and fetal
sheep were similar (p ⬎ 0.05), but were higher (p ⬍ 0.001) than
those of PrP-C in extraneural tissues and fetal fluids (Fig. 3,
A–C). In pregnant ewes, similar (p ⬎ 0.05) levels of PrP-C were
detected in caruncular endometrium, cotyledonary chorioallantois, and allantoic fluid (Fig. 3A). Likewise, intercaruncular
endometrium, myometrium, oviduct, ovary, fetal bladder, and
fetal kidney also had similar (p ⬎ 0.05) levels of PrP-C (Fig.
3A). However, PrP-C levels in caruncular endometrium, cotyledonary chorioallantois, and allantoic fluid were higher (p ⬍
0.05) than those in intercaruncular endometrium, myometrium, oviduct, ovary, fetal bladder, and fetal kidney. PrP-C in
intercotyledonary chorioallantois, amniotic fluid, amnion, urachus, and fetal urine was either very low or undetectable (Fig.
3A). In nonpregnant ewes, levels of PrP-C in endometrium,
myometrium, oviduct, and ovary were similar (p ⬎ 0.05) (Fig.
3B). PrP-C in pregnant caruncular endometrium was higher
(p ⬍ 0.05) by almost 4-fold than PrP-C in nonpregnant caruncular endometrium (Fig. 3C). Pregnancy had no effect on PrP-C
levels in myometrium, oviduct, and ovary (p ⬎ 0.05) (Fig. 3C).
PrP-C of the Uterus, Oviduct, Ovary, Cotyledonary Chorioallantois, Fetal Kidney, Fetal Bladder, and Allantoic Fluid
Is Differentially Glycosylated and N-terminal Truncated—
PrP-C in the ovine brain was consistently detected as multiple
bands with apparent molecular masses between 25 and 38 kDa
(Fig. 2). However, the apparent molecular masses of PrP-C in
reproductive, fetal, and placental tissues and fetal fluid were
variable between 23 and 37 kDa (Fig. 2). To determine whether
apparent variation of molecular masses of PrP-C isoforms in
brain, uterus, oviduct, ovary, cotyledonary chorioallantois, fetal kidney, fetal bladder, and allantoic fluid was a result of
differential glycosylation, tissue homogenates and allantoic
fluid were treated with endoglycosidase (PNGase F) to remove
the carbohydrate structures to assess the molecular mass of
PrP-C protein core (Fig. 4).
Treatment with endoglycosidase reduced the apparent
molecular mass of fetal and maternal brain PrP-C to ⬃18 –22
and ⬃29 kDa (Fig. 4, lanes m-bra and f-bra). Endoglycosidase
treatment of tissue homogenates of the uterine caruncular
endometrium, cotyledonary chorioallantois, intercaruncular
endometrium, myometrium, oviduct, ovary, and fetal bladder



FIG. 2. Representative Western blot analysis of PrP-C in maternal brain and reproductive tissues of pregnant (n ⴝ 6) and
nonpregnant (n ⴝ 4) ewes and in fetal and placental tissues and
fetal fluids (six fetal units were analyzed). A, tissues and fetal
fluids from a pregnant uninfected ewe analyzed with mAb 99/97; B,
tissues and fetal fluids from a pregnant uninfected ewe analyzed with
mAb 8H4; C, tissues from a nonpregnant uninfected ewe analyzed with
mAb 99/97. m-bra, maternal brain; ca-end, caruncular endometrium;
co-cho, cotyledonary chorioallantois; ico-cho, intercotyledonary chorioallantois; all-fl, allantoic fluid; amn-fl, amniotic fluid; ica-end, intercaruncular endometrium; myo, myometrium; ovi, oviduct; ova, ovary;
amn, amnion; ura, urachus; f-uri, fetal urine; f-bla, fetal bladder; f-kid,
fetal kidney; and f-bra, fetal brain. One to one and a half mg of tissue
homogenates (wet tissue equivalent) or 7–9 l of fetal fluids per lane
were used.
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FIG. 4. Representative results of deglycosylation of PrP-C in
brain, reproductive, fetal, and placental tissues and allantoic
fluid of pregnant uninfected ewes (n ⴝ 6). Tissue homogenates
(1–1.5 mg/lane wet tissue equivalent) or allantoic fluid (7–9 l/lane)
was treated with or without PNGase F at 37 °C overnight followed by
Western blot analysis using mAb 99/97. Similar results were also
shown for PrP-C in tissues from nonpregnant ewes (data not shown).
See Fig. 2 legend for explanation of abbreviations.

reduced the apparent molecular mass of PrP-C in these tissues
to ⬃18 –22 kDa with a minor species of 29 kDa in some tissues
(Fig. 4, lanes ca-end, co-cho, ica-end, myo, ovi, ova, and f-bla).
Allantoic fluid PrP-C was reduced by endoglycosidase treatment to ⬃16.5 kDa (Fig. 4, lane all-fl). Similar results were also
shown for PrP-C in tissues collected from nonpregnant ewes
(data not shown).
N-terminal truncation is common for PrP-C (26, 27) and,
therefore, was also investigated in this study. mAb 5B2 or 8B4,
which recognizes the N terminus of PrP, reacted to the fulllength PrP-C in maternal or fetal brain, but lacked reactivity to
isoforms of PrP-C present in uterine caruncular endometrium,
cotyledonary chorioallantois, allantoic fluid, uterine intercaruncular endometrium, myometrium, oviduct, ovary, fetal
bladder, and fetal kidney (data not shown). Neither mAb 99/97,
5B2, nor 8B4 detected PrP-C in intercotyledonary chorioallantois, amniotic fluid, amnion, urachus, or fetal urine (data not

The present study demonstrated that PrP-C was differentially expressed by tissues and fluids of the female reproductive
tract and conceptuses. Despite the wide distribution of PrP-C
in the reproductive, placental, and fetal tissues and fetal fluids,
PrP-Sc accumulation was only detected in the caruncular endometrium and cotyledonary chorioallantois of the placentome
from pregnant infected ewes. These results may implicate a
role of PrP-C in reproductive and fetal physiology and facilitate
a further understanding of prenatal, perinatal, and postnatal
transmission of scrapie under field conditions.
The biochemical properties of PrP-C in ovine reproductive,
fetal, and placental tissues and fetal fluids have not been
reported. This study used mAbs recognizing nonoverlapping
epitopes of PrP to characterize PrP-C in these tissues and
fluids. mAb binding showed that PrP-C in these tissues and
fluids had an intact C terminus; however, the N terminus of
PrP-C in reproductive, placental, and selected fetal tissues and

DISCUSSION



FIG. 3. Levels of PrP-C in reproductive, placental, fetal tissues,
and fetal fluids were determined in a fixed amount of tissue
homogenates or fetal fluids of pregnant and nonpregnant uninfected ewes. Affinity-purified roPrP (25 ng/lane), tissue homogenates
prepared from brain (0.15 mg/lane wet tissue equivalent), all other
tissues (1.5 mg/lane wet tissue equivalent), and fetal fluids (7–9 l/lane)
were analyzed by Western blotting using mAb 99/97. Films exposed to
Western blots for 1 min were analyzed by a digital imaging system. The
results are expressed as relative units, representing the ratio between
densitometric values of sample PrP-C and roPrP (25 ng). Data were
analyzed by one-way analysis of variance with Student-Newman-Keuls
multiple comparisons test. A, levels of PrP-C in tissues/fluids of pregnant uninfected ewes (tissues and fluids from six ewes and fetal units
were analyzed). B, levels of PrP-C in tissues of nonpregnant ewes
(tissues from four ewes were analyzed). C, comparison of PrP-C levels in
reproductive tissues of pregnant (n ⫽ 6) and nonpregnant (n ⫽ 4) ewes.
See Fig. 2 legend for explanation of abbreviations.

shown), further confirming the absence of PrP-C in these
tissues/fluids.
PK Susceptibility of PrP-C and PrP-Sc in the Reproductive,
Fetal, and Placental Tissues and Fetal Fluids of Normal and
Scrapie-infected Ewes—To determine whether the PrP detected in these tissues was susceptible to PK digestion, all
direct tissue homogenates, PrP-Sc-enriched tissue homogenates, and fetal fluids of uninfected and scrapie-infected ewes
were digested with PK and analyzed by Western blotting (Fig.
5). Results showed that PrP-C from fetal fluid and direct tissue
homogenates of pregnant uninfected ewes was susceptible to
PK digestion (Fig. 5A). Similar results were also shown for
PrP-C in tissues collected from nonpregnant ewes (data not
shown). No PrP-Sc was detected when tissues and fluids of
pregnant uninfected ewes were extracted with the procedure
used to prepare PrP-Sc-enriched tissue homogenates (data not
shown).
PK-resistant PrP-Sc was detected in enriched tissue homogenates of maternal brain, uterine caruncular endometrium,
and placental cotyledonary chorioallantois (Fig. 5B, lanes mbra, ca-end, and co-cho), but not in intercaruncular endometrium, myometrium, oviduct, ovary, fetal spleen, fetal bladder,
fetal kidney, and fetal brain (data not shown) from pregnant
scrapie-infected ewes and their conceptuses. The detection of
allantoic PrP-Sc was inconsistent due to the presence of endogenous protease inhibitors in allantoic fluid (data not shown)
(28, 29).

PrP-C and PrP-Sc at the Fetal-Maternal Interface

allantoic fluid was differentially truncated. After the N-linked
carbohydrate structures of PrP-C were removed, the protein
core of ⬃29 kDa may represent the full-length PrP-C and that
of ⬃18 –22 kDa may represent the N-terminally truncated,
potentially PK-resistant, C-terminal fragment of PrP-C (24,
26). These results suggest that PrP-C in these tissues and
allantoic fluid is differentially glycosylated and truncated, giving rise to various apparent molecular masses. The results are
consistent with the intrinsic partial protease resistance of the
C-terminal portion of PrP-C in several species (27), indicating
that an intermediate C-terminal fragment is present in many
of the peripheral tissues as a result of limited protease digestion of PrP-C prior to a complete proteolysis. The additional
truncation of PrP-C in allantoic fluid may indicate a further
processing by proteases in the allantoic fluid, which is suggested by the synthesis and secretion of a number of proteases
by the ovine placenta during pregnancy (30, 31).
The present study investigated the distribution of both
PrP-C and PrP-Sc in the ovine reproductive tract, placental
and selected fetal tissues, and fetal fluids. The findings suggest
potential sites of maternal transmission of scrapie. In sheep,
the ovum is released from the ovary at estrus, and it takes 3– 4
days for the ovum to reach the uterus through the oviduct,

where the ovum is fertilized to form an embryo. The embryo
will not be hatched from the zona pellucida, a noncellular
mucoprotein structure immediately surrounding the embryo,
until it is in the uterus. The present study showed that PrP-C,
but not PrP-Sc, was present in the ovine ovary and oviduct. Our
findings with four pregnant infected ewes are consistent with
the report that scrapie infectivity was absent from ovaries of
seven infected ewes (32). However, Hourrigan et al. (33) reported that scrapie infectivity was detected in ovaries of 4 of 14
ewes with unknown reproductive status. The presence of PrP-C
or PrP-Sc in the ova, preimplantation embryos, and the zona
pellucida with attached granulosa cells has not been reported.
Although studies using embryo transfer to determine scrapie
(34 –36) or bovine spongiform encephalopathy (37) transmission by preimplantation embryos were conducted by several
laboratories, the presence of PrP-Sc in embryos and disease
transmission through embryos remain inconclusive (20, 38,
39). More studies with larger sample size are needed to confirm
ovarian PrP-Sc using both bioassay and Western blotting.
PrP-C was abundantly present in the ovine uterus, which
confirmed the previous finding (4); our study extended that
observation by demonstrating that PrP-C was detectable in
direct tissue homogenates of separated caruncular and intercaruncular endometria and myometrium. In addition, higher
levels of PrP-C were detected in pregnant caruncular endometrium than in nonpregnant caruncular endometrium, suggesting that PrP-C is up-regulated during pregnancy. Since PrP-C
up-regulation was limited to the caruncular region (caruncles)
of the endometrium of pregnant ewes, it suggests that the
intimate cellular contact or factor(s) synthesized and released
by the apposing cotyledonary chorioallantois (cotyledon) as
well as pregnancy-associated hormones and cytokines at the
interface play a role in regulating PrP-C synthesis by the
maternal endometrium. Since the caruncular endometrium
is glandless and PrP-C was low in intercaruncular endometrium (rich in glands), PrP-C in caruncular endometrium may
be primarily contributed by the surface endometrial epithelium. The present study for the first time demonstrated that
PrP-Sc was present in the caruncular endometrium, but not in
intercaruncular endometrium of the uterus of pregnant
scrapie-infected ewes. These findings are consistent with the
observation that low levels of scrapie infectivity were present
in the ovine uterus, although the report provided no details on
reproductive status of the animals and specific parts of the
ovine uterus tested (33).
As the allantois grows during early gestation, it fuses with
the chorion to form chorioallantois, which establishes extensive
contact with the uterine endometrium at both caruncular and
intercaruncular regions. The most intimate contact between
the uterus and placenta is within the placentome (Fig. 1). In
contrast to the placentation of primates and rodents, the
conceptuses (fetus and associated membranes) of ruminants
establish interactions with the uterus through noninvasive
placentation within the uterine lumen. The cellular interactions and molecular exchange are active at the fetal-maternal
interface of placentomes where leakage of maternal blood by
endometrial villi and phagocytosis of maternal blood and degenerating endometrial cells by fetal trophoblast cells take
place (40 – 42). The placental trophoblast cells may acquire
nonspecifically pathogens at the interface during the physiological
process of uptake nutrients during gestation. The present study
and studies by others showed that scrapie infectivity (7–9, 43),
PrP-Sc (9), and PrP-C (44) are present in the ovine uterus and
placenta; therefore, PrP-Sc in the cotyledonary chorioallantois may
be derived from direct phagocytosis of or conversion by the maternal PrP-Sc in the caruncular endometrium of infected ewes.



FIG. 5. Representative results of PK susceptibility of PrP in
brain, reproductive, fetal, and placental tissues and fetal fluids
of uninfected (n ⴝ 6) and scrapie-infected (n ⴝ 4) ewes. Direct
tissue homogenates (1–1.5 mg/lane wet tissue equivalent), PrP-Sc-enriched tissue homogenates (15–30 mg/lane wet tissue equivalent), or
allantoic fluid (7–9 l/lane) were incubated with or without PK (20
g/ml) at 37 °C for 30 min, followed by Western blot analysis using mAb
99/97. A, PK treatment and Western blot analysis of direct tissue
homogenates of reproductive, fetal, and placental tissues and allantoic
fluid from a pregnant uninfected ewe; similar results were also shown
for PrP-C in tissues from nonpregnant uninfected ewes (data not
shown). B, PK treatment and Western blot analysis of PrP-Sc-enriched
tissue homogenates of caruncular endometrium and cotyledonary chorioallantois from a pregnant scrapie-infected ewe; PrP-Sc in other tissue homogenates was not detected (data not shown). See Fig. 2 legend
for explanation of abbreviations.
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As the embryo develops, the amnion is formed and filled with
amniotic fluid in which the embryo is suspended. The fetal
urine and lung liquid secretion are the primary sources for
amniotic fluid. The allantois is formed as a result of outgrowth
of the hindgut and filled with allantoic fluid surrounding the
amnion (Fig. 1). The allantoic fluid is primarily derived from
fetal urine drained from the bladder through the urachus.
Allantoic fluid may also be derived from chorioallantois secretion (45). The present study showed that high levels of soluble
PrP-C were present in allantoic fluid, but not in other fetal
fluids such as amniotic fluid and fetal urine. The source for
allantoic fluid PrP-C was not directly determined. The absence
of detectable PrP-C in fetal urine and amnion fluid shown in
this study may indicate that fetal kidney, bladder, and urachus
do not secret detectable PrP-C into the urine, although PrP-C is
synthesized by the kidney and bladder. Thus, we conclude that
cotyledonary chorioallantois may be the primary source for
allantoic PrP-C. The presence of PK-resistant allantoic PrP
could not be demonstrated in the present study due to the
presence of protease inhibitors in allantoic fluid.
Taken together, it appears that PrP-Sc is only present in
tissues (such as caruncular endometrium and cotyledonary
chorioallantois) expressing high levels of PrP-C, and the embryo/fetus is physically separated from the PrP-rich allantoic
fluid and chorioallantois by the amnion, which has no detectable PrP-C. Based on the results of this study and previous
reports, we propose that the ovine embryo/fetus may not be
exposed to scrapie prior to parturition. The oocyte or early
conceptus may not be exposed to PrP-Sc prior to hatching in the
uterus, because the presence of an intact zona pellucida at this
stage may protect the embryos from infection, as suggested by
studies of a number of other pathogens (46). The hatched,
preimplantation embryo may not be exposed to PrP-Sc due to
the formation of extraembryonic membranes. After placentation, the fetus may not be exposed to PrP-Sc due to the presence
of a PrP-negative zone, the amnion, around the developing
fetus during the gestational period. A neonate is most likely to
be exposed to PrP-Sc during or after parturition when fetal
membranes are broken and chorioallantoic tissues and allantoic fluid contaminate the birth canal, body surface, and wool of
both the mother and neonate, mammary glands, and the lambing area. PrP-Sc from both fetal membranes and fluids may
serve as a source for horizontal transmission of scrapie under
natural conditions (7). Overall, we propose that 1) the embryos/
fetuses are less likely to be exposed to scrapie in utero, 2) lambs
are likely to be exposed to scrapie at birth and during nursing,
and 3) wasted placenta and possibly allantoic fluid of infected ewes may serve as a primary source for horizontal
transmission.
The results of this study provide useful information for
a better understanding of maternal transmission of scrapie
during the prenatal, perinatal, and postnatal periods. Despite
some differences in placentation among different species, ovine
scrapie represents a valuable model for investigating PrP-Sc
replication at the fetal-maternal interface in prion diseases such
as chronic wasting disease and variant Creutzfeldt-Jakob disease, in which PrP-Sc is distributed outside of the nervous system (47, 48). These results also contribute to our understanding
of the regulation of PrP-C at different stages of pregnancy and
fetal development and the role of PrP-C in fetal-maternal
interactions at the interface.

